Fig. 3
(Adapted with permission from the Journal of Investigational Allergology and Clinical Immunology)
Effect of MP-AzeFlu (n = 388, blue) and fluticasone propionate (FP; n = 199, orange) on reflective total nasal symptom score (rTNSS) in patients with chronic rhinitis. Data are presented as least squares (LS) mean change from baseline at 4-week intervals. MP-AzeFlu a novel formulation of an intranasal antihistamine, azelastine hydrochloride, and an intranasal corticosteroid, fluticasone propionate, in a single spray, rTNSS, reflective total nasal symptom score. *p ≤ 0.0453 versus MP-AzeFlu